PCa CSCs exhibit a high expression of ABCG2 (13), a transporter used by several chemotherapeutic drugs, suggesting that CSCs may be responsible for the increased MDR phenotype of PCa tumors. The gene discussed is ABCG2; the disease is posterior cortical atrophy.